| Similar Articles |
|---|
 |
The Motley Fool
May 18, 2011
Sean Williams |
10 Mid Caps to Rule Them All The future of Jazz Pharmaceuticals' narcolepsy drug is so bright you may actually sleep better at night.   |
The Motley Fool
January 10, 2012
Sean Williams |
Could This Stock Nearly Double 2 Years In a Row? Up 96% in 2011, there's a decent chance at a Jazz Pharmaceuticals repeat in 2012. |
The Motley Fool
January 3, 2011
Travis Hoium |
Inspire Pharmaceuticals Shares Plunged: What You Need to Know The new trading year came in with a loud thud for Inspire Pharmaceuticals when its stock fell 58% this morning. |
The Motley Fool
August 23, 2010
Brian Orelli |
No Way to Jazz Up This Result Jazz Pharmaceuticals investors went from ecstatic to devastated in less than a week. |
The Motley Fool
August 18, 2010
Brian Orelli |
No Pain Here as Jazz Shares Rocket Investors are all jazzed up about Jazz Pharmaceuticals |
The Motley Fool
October 12, 2010
Travis Hoium |
King Pharmaceuticals Shares Popped: What You Need to Know King Pharmaceuticals shares are up nearly 40% today after it was announced the company would be purchased by Pfizer Inc. |
The Motley Fool
October 11, 2010
Brian Orelli |
FDA Rejection, but Still Jazzed Up Sometimes, biotechs are like that. |
The Motley Fool
March 25, 2011
Selena Maranjian |
Make Money in Pharmaceuticals the Easy Way There's no need to guess which pharmaceutical company will perform best with the SPDR S&P Pharmaceuticals ETF. |
The Motley Fool
January 13, 2004
Jeff Hwang |
Eon Labs' Potent Potential The generic drug maker's fourth-quarter estimates spiked higher. |
The Motley Fool
November 29, 2005
Rich Duprey |
Spansion's Expanding Losses Pre-IPO flash memory unit of AMD reports that it will have a larger fourth-quarter loss. |
The Motley Fool
December 28, 2007
Brian Orelli |
The Biggest Health-Care IPOs of 2007 Let's take a look at four of the most intriguing health care IPOs from 2007. |
The Motley Fool
September 3, 2011
Seth Jayson |
A Hidden Reason Why the Future Looks Bright for Jazz Pharmaceuticals Jazz Pharmaceuticals seems to be handling inventory well enough, but the individual segments don't provide a clear signal. |
The Motley Fool
November 13, 2009
Rich Duprey |
5 Stocks That Laugh at Wall Street These companies' earnings handily beat analyst forecasts: General Steel... Jazz Pharmaceuticals... MGM Mirage... Stillwater Mining... Penn West Energy... |
AskMen.com
Ryan McKee |
How To: Keep Up In A Jazz Conversation If you can hold your own and keep up in a jazz conversation, women will think you're deep, with art appreciation coursing through your veins. |
The Motley Fool
May 24, 2011
Morgan Housel |
Awaiting the Next Crash The big panic of May 6, 2010 that harmed almost no one. |
The Motley Fool
January 27, 2005
W.D. Crotty |
Time to Delete Lexar? Watch your portfolio: Company expects a sharp loss as flash memory prices fall. |
Bio-IT World
May 2006
G. Steven Burrill |
Biotech Turns in Mixed Q1 Performance Biotech closed out a rough month of March, but this did not take the shine off the exceptional performance of the mid- and small-cap biotech companies. |
The Motley Fool
October 17, 2005
Dan Bloom |
NAND Flash Dazzles Investors More devices are using NAND flash -- but manufacturers' profits aren't guaranteed. Investors, take note. |
Chemistry World
January 27, 2014
Jennifer Newton |
Jazz spending spree has ups and downs Jazz Pharmaceuticals has agreed with Aerial Bio Pharma to acquire the rights to ADX-N05, a drug designed to treat narcolepsy. |
The Motley Fool
August 17, 2010
Travers & Jayson |
Is Alexion Pharmaceuticals Burning Out? The first step toward finding a promising biotech company is not to figure out whether the science is any good, but to make sure that the company is financially healthy. |
The Motley Fool
August 27, 2010
Travers & Jayson |
The Most Important Thing about Regeneron Pharmaceuticals Stop obsessing about the science. |
The Motley Fool
August 26, 2010
Travers & Jayson |
Will Onyx Pharmaceuticals Burn You? Is Onyx Pharmaceuticals on strong financial footing? |
The Motley Fool
August 18, 2010
Travers & Jayson |
Will Endo Pharmaceuticals Holdings Burn You? Endo Pharmaceuticals Holdings is cash flow-positive, and has been for quite some time. That's investment nirvana for biotech shareholders. |
The Motley Fool
October 25, 2008
Selena Maranjian |
The Market Crashed -- Now What? Although we never know when the next market crash will happen, we know a little something about what happens after the market goes down. |
The Motley Fool
August 17, 2010
Travers & Jayson |
How Long Can Amylin Pharmaceuticals Last? You don't need an advanced degree in pharmacology to find biotech companies with a legitimate chance of hitting it big. |
The Motley Fool
August 2, 2004
Charly Travers |
What's a Drug Worth? The value of small biotech companies is in their investigational drug programs. |
The Motley Fool
September 12, 2005
Seth Jayson |
News Flash? Yeah, Right. Investors looking to cash in on the growing demand for flash memory would do best to look past Samsung and Toshiba, the giant conglomerates making the raw memory. Instead, they should seek opportunities from flash-systems provider M-Systems or SanDisk or even Lexar Media. |
Smithsonian
November 2005
Tom Piazza |
35 Who Made a Difference: Wynton Marsalis In Katrina's aftermath, the trumpeter has rallied support for his native New Orleans. |
The Motley Fool
December 15, 2011
David Williamson |
1 Massive Biotech Bloodbath Trial results and FDA panels ruled the health-care sector today. |
InternetNews
May 13, 2011 |
Flash Player 10.3 Fixes 11 Flaws, Updates Privacy If you're running Adobe's Flash Player, it's time to update Flash, again. |
The Motley Fool
August 14, 2011
Rex Moore |
Warning: Vertex Pharmaceuticals May Be Hiding Weakness Here are Vertex Pharmaceuticals' numbers, as well as a bonus look at a few other companies in its industry. |
The Motley Fool
May 31, 2006
Dan Bloom |
NOR Flash's Time to Shine? iSuppli believes that a NOR flash shortage may materialize this year, and Spansion shareholders stand to benefit. |
The Motley Fool
November 16, 2011
David Williamson |
3 Biotechs Beating the Market The daily health-care news investors need to read. |
The Motley Fool
October 4, 2010
Dan Caplinger |
Don't Buy an ETF Without Reading This The flash crash spells big danger for ETFs. |
The Motley Fool
January 25, 2005
Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs. |
The Motley Fool
November 10, 2011
Evan Niu |
Steve Jobs' Latest Victory Adobe is abandoning Flash development for mobile devices and TVs. |
The Motley Fool
March 13, 2009
Dan Caplinger |
How the Best Investors Beat the Bear While it may take years for you to recover your precrash net worth, don't give up. You can get there eventually, as long as you avoid big mistakes and maintain the confidence to keep following your investing plan. |
AskMen.com
Christian Chensvold |
Introducing AM's Jazz Style Icons AskMen.com is kicking off a series of style icon profiles of four jazz artists: Miles Davis, Gerry Mulligan, Bill Evans, and Chet Baker. |
